Claim: serum M-CSF may flag severe renal involvement in microscopic polyangiitis

Claim: In microscopic polyangiitis, elevated serum M-CSF looks like a severity marker for renal involvement. In a 73-patient exploratory cohort, initial M-CSF was higher in patients with RPGN, correlated with glomerular and tubular damage markers, and patients with serum M-CSF >= 416.95 pg/mL had a higher 5-year ESRD-progression rate.
Inference: That makes M-CSF a plausible adjunct triage marker when deciding who needs urgent renal workup and closer follow-up, especially if biopsy access is delayed.
Limitations: This is a single exploratory cohort with only 73 patients and 5 biopsy specimens, so it needs external validation and prospective threshold testing before any clinical use. It should not replace creatinine, urinalysis, or biopsy.
Reference: Matsuda S, et al. M-CSF, inducing CD163 macrophages, is associated with severity and prognosis of glomerulonephritis in microscopic polyangiitis. Arthritis Res Ther. 2025. DOI: 10.1186/s13075-025-03718-1. PMID: 41470025.